Daniel Schneeberger, 10% Owner of InMed Pharmaceuticals INM, has filed 19 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $90.7M. The latest trade was on 05/19.

DS

DS

Daniel Schneeberger

10% Owner

Company

InMed Pharmaceuticals INM

First filing

25/04/11

Trades

37 trades

Buys / sales

19 / 3

12-month net buying

−$90.7M

Last trade

05/19

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
InMed PharmaceuticalsINM	Open-market buy	05/19	05/21	468,551 sh3 trades	$1.54avg.	$721,681.6	+141.4%
RallybioRLYB	Open-market buy	05/18–05/19	05/20	16,209 sh3 trades	$13.98avg.	$226,565.82	+1.8%
RallybioRLYB	Open-market buy	05/13–05/15	05/15	79,559 sh4 trades	$13.99avg.	$1,112,979.8	+9.6%
RallybioRLYB	Open-market buy	05/11–05/12	05/13	50,800 sh4 trades	$14.00avg.	$711,064	+6.5%
RallybioRLYB	Open-market buy	05/04–05/05	05/06	155,905 sh3 trades	$13.98avg.	$2,178,772.88	+25.0%
Keros TherapeuticsKROS	Open-market sale	25/10/15	25/10/15	5,389,264 sh3 trades	$17.75avg.	$95,659,436	−100.0%
Keros TherapeuticsKROS	Open-market buy	25/04/09	25/04/11	934,258 sh5 trades	$10.13avg.	$9,465,654.89	+27.0%